Free Trial

Zepp Health Co. (NYSE:ZEPP) Sees Significant Growth in Short Interest

Zepp Health logo with Medical background

Zepp Health Co. (NYSE:ZEPP - Get Free Report) was the target of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 24,000 shares, a growth of 57.9% from the September 30th total of 15,200 shares. Based on an average trading volume of 22,400 shares, the short-interest ratio is presently 1.1 days. Approximately 0.3% of the shares of the stock are sold short.

Zepp Health Trading Down 0.9 %

Shares of Zepp Health stock traded down $0.03 on Friday, hitting $3.37. The stock had a trading volume of 10,455 shares, compared to its average volume of 32,194. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.02 and a current ratio of 1.39. Zepp Health has a twelve month low of $2.06 and a twelve month high of $8.40. The stock has a 50 day moving average of $3.35 and a 200 day moving average of $3.05. The firm has a market capitalization of $202.90 million, a P/E ratio of -8.43 and a beta of 0.64.

Zepp Health (NYSE:ZEPP - Get Free Report) last announced its earnings results on Wednesday, August 21st. The company reported ($0.68) EPS for the quarter. The company had revenue of $40.64 million for the quarter. Zepp Health had a negative return on equity of 7.72% and a negative net margin of 10.60%.

Zepp Health Company Profile

(Get Free Report)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

Read More

Should you invest $1,000 in Zepp Health right now?

Before you consider Zepp Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.

While Zepp Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines